Related Experiment Video
Updated: Jun 5, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Early-childhood neurodevelopmental outcomes are not improving for infants born at <25 weeks' gestational age
Susan R Hintz1, Douglas E Kendrick, Deanne E Wilson-Costello
1Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, 750 Welch Rd, Suite 315, Palo Alto, CA 94304, USA. srhintz@stanford.edu
Insights
Neurodevelopmental outcomes for extremely low birth weight infants born before 25 weeks
Area of Science:
- Neonatalogy
- Developmental Pediatrics
- Perinatology
Background:
- Extremely low birth weight infants (born <25 weeks estimated gestational age) face significant neurodevelopmental challenges.
- Changes in neonatal care practices may impact outcomes over time.
Purpose of the Study:
- To compare neurodevelopmental outcomes at 18 to 22 months corrected age for infants born extremely prematurely.
- To assess changes in outcomes between two distinct care epochs (1999-2001 and 2002-2004).
Main Methods:
- Retrospective multicenter analysis using Neonatal Research Network data.
- Comparison of perinatal and neonatal variables between the two epochs.
- Neurodevelopmental assessment using neurologic exams and Bayley Scales of Infant Development II.
Main Results:
- Infant survival rates were similar between epochs (35.4% vs 32.3%).
- Cesarean delivery, patent ductus arteriosus surgery, and late sepsis increased in the later epoch.
- Postnatal steroid use significantly decreased (63.5% vs 32.8%).
- Adverse neurodevelopmental outcomes, including cerebral palsy and low Mental Developmental Index scores, remained common and showed no significant change between epochs.
Conclusions:
- Despite changes in care practices like reduced postnatal steroid use, early-childhood neurodevelopmental outcomes for extremely preterm infants (<25 weeks GA) did not significantly improve between the two study periods.
- Continued research is needed to identify interventions that can improve long-term neurodevelopmental trajectories in this vulnerable population.
Objective:
We compared neurodevelopmental outcomes at 18 to 22 months' corrected age of infants born with extremely low birth weight at an estimated gestational age of <25 weeks during 2 periods: 1999-2001 (epoch 1) and 2002-2004 (epoch 2).
Patients And Methods:
We conducted a multicenter, retrospective analysis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Perinatal and neonatal variables and outcomes were compared between epochs. Neurodevelopmental outcomes at 18 to 22 months' corrected age were evaluated with neurologic exams and Bayley Scales of Infant Development II. Logistic regression analyses determined the independent risk of epoch for adverse outcomes.
Results:
Infant survival was similar between epochs (epoch 1, 35.4%, vs epoch 2, 32.3%; P = .09). A total of 411 of 452 surviving infants in epoch 1 and 405 of 438 surviving infants in epoch 2 were evaluated at 18 to 22 months' corrected age. Cesarean delivery (P = .03), surgery for patent ductus arteriosus (P = .004), and late sepsis (P = .01) were more common in epoch 2, but postnatal steroid use was dramatically reduced (63.5% vs 32.8%; P < .0001). Adverse outcomes at 18 to 22 months' corrected age were common in both epochs. Moderate-to-severe cerebral palsy was diagnosed in 11.1% of surviving infants in epoch 1 and 14.9% in epoch 2 (adjusted odds ratio [OR]: 1.52 [95% confidence interval (CI): 0.86-2.71]; P = .15), the Mental Developmental Index was <70 in 44.9% in epoch 1 and 51% in epoch 2 (OR: 1.30 [95% CI: 0.91-1.87]; P = .15), and neurodevelopmental impairment was diagnosed in 50.1% of surviving infants in epoch 1 and 58.7% in epoch 2 (OR: 1.4 [95% CI: 0.98-2.04]; P = .07).
Conclusions:
Early-childhood outcomes for infants born at <25 weeks' estimated gestational age were unchanged between the 2 periods.
Related Concept Videos
Neurulation
Teratogenicity

